s/
Stockslash
⌘K
Stocks
LAB
Not investment advice · 13F data lagged ~45 days · Full disclaimer
LA

Standard Biotools

LAB13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying LAB

Top funds mostly added to Standard Biotools in Q1 (Jan⁠–⁠Mar)

Buying:
Funds1Insiders1Congress
1 fund$48.3M held0.1% avg. weightQ1: 1 bought / 0 sold
13F reports are a snapshot as of Mar 31, 2024; funds may have traded since.
Share price · market data, not from 13F reports
Q2 2026
Insider trades (Form 4)
Last 2 years · 18 filings
Net buying$21.49M
DateInsiderTypeSharesPriceValue
Dec 2, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought350,000$1.44$503K
Nov 24, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought7,700,000$1.31$10.05M
Nov 18, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought1,075,000$1.28$1.37M
Nov 13, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought925,000$1.22$1.13M
Nov 7, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought1,175,000$1.17$1.38M
Sep 9, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought100,000$1.29$129K
Sep 3, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought500,000$1.27$636K
Aug 22, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought525,000$1.25$659K
Aug 13, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought358,220$1.24$443K
May 23, 2025
Hanjoon Alex Kim
CFO
Sold1,428$0.94$1K
May 23, 2025
Sean Mackay
VP
Sold13,217$0.94$12K
May 23, 2025
Michael Egholm
President & CEO
Sold5,473$0.94$5K
May 22, 2025
Hanjoon Alex Kim
CFO
Sold1,355$1.00$1K
May 22, 2025
Michael Egholm
President & CEO
Sold5,116$1.00$5K
May 21, 2025
Sean Mackay
VP
Sold25,374$1.02$26K
May 21, 2025
Michael Egholm
President & CEO
Sold4,719$1.03$5K
May 21, 2025
Hanjoon Alex Kim
CFO
Sold1,407$1.03$1K
Feb 28, 2025
Casdin Partners Master Fund, L.P.
Director & 10% Owner
Bought4,820,959$1.07$5.13M